Cohesin enables post-replicative DNA repair and chromosome segregation by holding sister chromatids together from the time of DNA replication in S-phase until mitosis^[@R1]^. There is growing evidence that cohesin also forms long range chromosomal cis-interactions^[@R2]--[@R4]^ and may regulate gene expression^[@R2]--[@R10]^ in association with CTCF (ref. [@R8], [@R9]), mediator^[@R4]^ or tissue-specific transcription factors^[@R10]^. Human cohesinopathies like Cornelia de Lange Syndrome are thought to result from impaired non-canonical cohesin functions^[@R7]^, but a clear distinction between cohesin\'s cell division-related and cell division-independent functions as exemplified in Drosophila^[@R11]--[@R13]^ has not been demonstrated in vertebrate systems. To address this, we deleted the cohesin locus *Rad21* in mouse thymocytes at a time in development when these cells stop cycling and rearrange their T cell receptor alpha locus (*Tcra*). *Rad21* deficient thymocytes had a normal lifespan and retained the ability to differentiate, albeit with reduced efficiency. Loss of *Rad21* led to a defective chromatin architecture at the *Tcra* locus, where cohesin binding sites flank the TEA promoter and the Eα enhancer, and demarcate *Tcra* from interspersed *Tcrd* elements and neighbouring housekeeping genes. Cohesin was required for long-range promoter-enhancer interactions, *Tcra* transcription, H3K4me3 histone modifications that recruit the recombination machinery^[@R14],[@R15]^ and *Tcra* rearrangement. Provision of pre-rearranged T cell receptor transgenes largely rescued thymocyte differentiation, demonstrating that among thousands of potential target genes across the genome^[@R4],[@R8]--[@R10]^ defective *Tcra* rearrangement was limiting for the differentiation of cohesin-deficient thymocytes. These findings firmly establish a cell division-independent role for cohesin in *Tcra* locus rearrangement and provide a comprehensive account of the mechanisms by which cohesin enables cellular differentiation in a well-characterised mammalian system.

The somatic rearrangement of lymphocyte receptor loci is central to adaptive immunity^[@R16]^. Gene segments distributed over millions of base pairs of genomic DNA are transcribed, brought into proximity with each other, and recombined in a cell lineage- and developmental stage-specific fashion^[@R17]--[@R19]^. In developing thymocytes, proliferation and differentiation are tightly linked and the activity of Rag (recombinase activating gene) proteins is restricted to the G1 phase of the cell cycle^[@R20]^. Early thymocytes at the CD4^−^ CD8^−^ double negative (DN) stages 1 and 2 proliferate in response to cytokines and briefly arrest at the DN3 stage, where they rearrange the T cell receptor (TCR) beta locus ([Fig. 1a](#F1){ref-type="fig"}). Pre-T cell receptor signals drive a phase of proliferation that extends to the early CD4^+^ CD8^+^ double positive (DP) stage. Shortly after the acquisition of CD4 and CD8, DP thymocytes lose the expression of the transferrin receptor CD71 (ref. [@R21]) and become small, non-proliferating CD71^−^ DP cells ([Fig. 1a](#F1){ref-type="fig"}), which represent the great majority of thymocytes. During their life span of 3 to 4 days, DP thymocytes undergo multiple rounds of TCR alpha (*Tcra*) rearrangement^[@R16],[@R18],[@R19]^. Successful TCR expression and engagement selects a minority (3--5%) of DP thymocytes for differentiation via a CD4^+^ CD8^lo^ intermediate stage towards long-lived CD4 or CD8 SP cells, again with minimal proliferation^[@R16],[@R22]^ ([Fig. 1a](#F1){ref-type="fig"}).

To address the role of cohesin in *Tcra* rearrangement and thymocyte differentiation we combined a conditional allele encoding the cohesin subunit Rad21 (*Rad21*^lox^, [fig. 1b](#F1){ref-type="fig"}, [Supplementary Fig. 1a](#SD2){ref-type="supplementary-material"}) with a Cre transgene under the control of *Cd4* regulatory elements (CD4Cre), which becomes active at the transition from the CD4^−^ CD8^−^ DN to the DP stage^[@R23]^. Pilot experiments with YFP reporters showed CD4Cre-dependent accumulation of YFP after the CD71^+^ proliferative stage in non-dividing DP thymocytes ([Supplementary fig. 1b](#SD2){ref-type="supplementary-material"}). Proliferating CD4Cre *Rad21*^lox/lox^ CD71^+^ DP cells showed partial locus deletion but retained \>50% *Rad21* mRNA and protein ([Fig. 1c](#F1){ref-type="fig"}). *Rad21* genomic deletion was essentially complete (\>97%) and *Rad21* RNA and protein levels were substantially reduced in non-dividing DP thymocytes ([Fig. 1c](#F1){ref-type="fig"}). Hence, cohesin was selectively depleted from non-dividing thymocytes. Importantly, CD4Cre *Rad21*^lox/lox^ DP thymocyte numbers were normal ([Fig. 1d](#F1){ref-type="fig"}). Intermediate CD4^+^8^lo^ and mature CD4 SP and CD8 SP thymocytes accumulated slowly in CD4Cre *Rad21*^lox/lox^ mice ([Supplementary fig. 2a](#SD2){ref-type="supplementary-material"}) but were present in normal numbers by 6 weeks of age ([Fig. 1d](#F1){ref-type="fig"}).

Bromodeoxyuridine (BrdU) incorporation into replicating DNA can identify proliferating thymocyte populations and track their differentiation^[@R22]^. Pulse-chase experiments labeled proliferating (CD71^+^) DP but not non-proliferating CD4^+^8^lo^, CD4 SP or CD8 SP thymocytes^[@R22]^ ([Fig. 1e](#F1){ref-type="fig"}, 2 hour time point). During the subsequent chase period, BrdU-labeled DP cells differentiated to become CD4^+^8^lo^ and eventually CD4 or CD8 SP ([Fig. 1e](#F1){ref-type="fig"}, left panel). This sequence of differentiation was preserved in CD4Cre *Rad21*^lox/lox^ thymocytes, but the proportion of DP thymocytes that became CD4 SP or CD8 SP was reduced ([Fig. 1e](#F1){ref-type="fig"}, right panel, and [supplementary fig. 2b](#SD2){ref-type="supplementary-material"}).

In continuous BrdU labeling experiments, the percentage of BrdU^+^ cells indicates population turnover^[@R22]^. Importantly, cohesin-deficient and control DP thymocytes labeled with similar kinetics ([Fig. 1f](#F1){ref-type="fig"}). Consistent with the pulse-labeling data ([Fig. 1e](#F1){ref-type="fig"}), the accumulation of CD4^+^8^lo^, and CD4 SP subsets was reduced in CD4Cre *Rad21^lox/lox^* mice ([Supplementary fig. 2c](#SD2){ref-type="supplementary-material"}). Hence, cohesin depletion impaired the differentiation of DP thymocytes, but not their survival.

Unlike many other differentiated cell types, mature thymocytes can be induced to re-enter the cell cycle. *In vitro* activated CD4Cre *Rad21*^lox/lox^ CD4 SP thymocytes showed abnormal mitotic figures with multiple spindles, chromosome segregation defects ([Fig. 1g](#F1){ref-type="fig"}, [supplementary fig. 3](#SD2){ref-type="supplementary-material"}), and poor survival ([Fig. 1g](#F1){ref-type="fig"}). CD4Cre-mediated deletion of *Rad21* therefore generates thymocytes that die when forced to divide, yet have a normal lifespan as non-dividing cells *in vivo*. This affords the interrogation of cohesin functions in interphase, independent of essential cohesin functions during cell division.

Rad21 chromatin immunoprecipitation and sequencing (ChIP-seq) mapped cohesin to key positions within the *Tcra* locus in DP thymocytes ([Fig. 2a](#F2){ref-type="fig"}). Cohesin was abundant at the locus control region^[@R24]^, which separates the *Tcra* enhancer, Eα, from the neighbouring *Dad1* housekeeping gene^[@R25],[@R26]^. Other prominent cohesin sites separated the *Tcra* TEA promoter from the *Tcrd* enhancer, Eδ, which controls *Tcrd* gene segments that are interspersed within the *Tcra* locus but follow a distinct developmental stage-specific programme^[@R18]^. Cohesin colocalisation with the insulator protein CTCF (ref. [@R8], [@R9]) is found at the *Dad1* site 10kb downstream of Eα, while at the Jα49 promoter cohesion associates with its loading protein Nipbl and mediator subunits^[@R4]^ more than with CTCF ([Supplementary fig. 4](#SD2){ref-type="supplementary-material"}). Interestingly, the major *Tcra* regulatory elements Eα and TEA bound copious amounts of cohesin, Nipbl, and mediator as well as CTCF ([Supplementary fig. 4](#SD2){ref-type="supplementary-material"}).

RNA-sequencing (RNA-seq) indicated that *Tcra* constant region (Cα) transcripts were considerably more abundant than transcripts from the neighbouring *Dad1* gene and the *Tcrd* constant region (Cδ) in control DP thymocytes. In cohesin-depleted small DP thymocytes, Cδ and *Dad1* transcripts were elevated at the expense of Cα transcripts ([Fig. 2b](#F2){ref-type="fig"}) as confirmed by real time RT-PCR ([Supplementary fig. 5a](#SD2){ref-type="supplementary-material"}). Moreover, transcription across the *Tcra* joining elements, Jα, was skewed: control DP thymocytes preferentially transcribed distal (3\') Jα elements, while cohesin-depleted DP thymocytes preferentially transcribed proximal (5\') Jα elements ([Fig. 2b](#F2){ref-type="fig"}).

Transcription of lymphocyte receptor loci facilitates rearrangement^[@R27]^ in part via the trimethylation of histone H3 at lysine 4 (H3K4me3). H3K4me3 recruits Rag2 protein^[@R14],[@R15],[@R28]^, which together with Rag1 forms the recombinase complex^[@R18]^. ChIP showed reduced H3K4me3 deposition ([Fig. 2c](#F2){ref-type="fig"}) and Rag binding ([Fig. 2d,e](#F2){ref-type="fig"}) at distal Jα elements in CD4Cre *Rad21*^lox/lox^ DP thymocytes. Hence, cohesin deficiency affected *Tcra* transcription, H3K4me3 histone modifications and the recruitment of Rag recombinases.

Primary *Tcra* rearrangements involve proximal (5') Jα elements and occur in early CD71^+^ DP thymocytes, while secondary rearrangements involve progressively more distal (3') Jα elements in non-dividing DP thymocytes^[@R18]^ ([Supplementary fig. 1b](#SD2){ref-type="supplementary-material"}). CD71^+^ DP CD4Cre *Rad21*^lox/lox^ thymocytes had near-normal Rad21 protein levels ([Fig. 1c](#F1){ref-type="fig"}) and Cδ, Cα and *Dad1* transcription ([Supplementary fig. 5b](#SD2){ref-type="supplementary-material"}), and primary rearrangements of proximal Jα elements were present at normal levels ([Fig. 3a, b](#F3){ref-type="fig"}). In contrast, secondary *Tcra* rearrangements were substantially impaired in non-dividing CD4Cre *Rad21*^lox/lox^ DP thymocytes ([Fig. 3a, b](#F3){ref-type="fig"}), which were depleted of cohesin ([Fig. 1c](#F1){ref-type="fig"}). The usage of the distal Jα22 element, for example, was reduced on average by 86% ([Fig. 3b](#F3){ref-type="fig"}, middle), reflecting a progressive under-representation of 3' Jα segments ([Fig. 3b](#F3){ref-type="fig"}, right). This was confirmed by analysis of additional Vα gene families ([Supplementary fig. 6a](#SD2){ref-type="supplementary-material"}) and by RT-PCR-based copy number analysis of mature *Tcra* transcripts ([Supplementary fig. 6b](#SD2){ref-type="supplementary-material"}). Therefore, primary rearrangements occurred before the depletion of cohesin, while reduced cohesin expression impaired secondary rearrangements in non-dividing DP thymocytes. Normal BrdU labeling kinetics ([Fig. 1f](#F1){ref-type="fig"}) exclude decreased lifespan as an explanation for aberrant *Tcra* rearrangement^[@R29]^. Consistent with the defective recruitment of Rag proteins to the *Tcra* locus ([Fig2d, e](#F2){ref-type="fig"}), double strand breaks were reduced in cohesin-deficient thymocytes ([Fig. 3c](#F3){ref-type="fig"}). This identifies Rag cleavage, rather than double strand break repair as the limiting step for *Tcra* rearrangements in cohesin-deficient thymocytes.

Since *Tcra* rearrangement changes the positioning of regulatory elements^[@R18]^, altered *Tcra* transcription ([Fig. 2b](#F2){ref-type="fig"}) could either be a direct consequence of cohesin depletion, or result indirectly from defective rearrangement. To distinguish between these possibilities we compared intronic *Tcra* transcript copy numbers in the absence of rearrangement in *Rag1*-deficient CD4Cre *Rad21*^lox/wt^ and CD4Cre *Rad21*^lox/lox^ DP thymocytes. Cohesin depletion reduced the transcription ([Fig. 4a](#F4){ref-type="fig"}) and H3K4me3 ([Supplementary fig. 7](#SD2){ref-type="supplementary-material"}). at Jα independently of *Tcra* rearrangement.

To explore how cohesin affects *Tcra* transcription we analysed long-range interactions between the TEA promoter and Eα, which are separated by approximately 80 kb of genomic DNA and together regulate the transcription of *Tcra*. In chromosome conformation capture (3C) assays^[@R30]^, Eα interacted strongly with TEA in DP thymocytes ([Fig. 4b](#F4){ref-type="fig"}) but cohesin depletion reduced these interactions to the level found in pre-B cells, where *Tcra* is not detectably transcribed ([Fig. 4b](#F4){ref-type="fig"}). Hence, the extent of *Tcra* enhancer-promoter interactions was cell type-specific, correlated with *Tcra* transcription, and was cohesin-dependent. A role for cohesin in additional enhancer-promoter interactions during sequential *Tcra* rearrangements is suggested by Eα contacts with promoters between Jα49 and Jα37 ([Fig. 4b](#F4){ref-type="fig"}), which can drive Jα transcription in the absence of TEA^[@R18]^, and by the cohesin binding to numerous Vα promoters ([Fig. 2a](#F2){ref-type="fig"}). Cohesin depletion also affected Eα interactions with the neighbouring *Dad1* cohesin site, and therefore the topology of the *Tcra* locus control region^[@R24]^, which has CTCF-dependent transcriptional insulator function^[@R25],[@R26]^ ([Fig. 4b](#F4){ref-type="fig"}). As cohesin mediates CTCF-dependent transcriptional insulation^[@R8],[@R9]^, increased *Dad1* expression at the expense of Cα ([Fig. 2b](#F2){ref-type="fig"}) may indicate impaired insulator function.

To test whether aberrant *Tcra* rearrangement caused inefficient differentiation we equipped cohesin-deficient thymocytes with transgenes encoding rearranged TCRs. Compared to endogenously rearranged TCRs ([Fig. 4c](#F4){ref-type="fig"}, top), the expression of MHC class II ([Fig. 4c](#F4){ref-type="fig"}, middle) or MHC class I restricted TCRs ([Fig. 4c](#F4){ref-type="fig"}, bottom) markedly improved the generation of CD4Cre *Rad21*^lox/lox^ CD4^+^8^lo^ and SP thymocytes.

In summary, cohesin shapes the chromatin architecture of the *Tcra* locus by mediating cell type-specific long-range interactions between enhancer and promoter elements that control transcription, H3K4me3 deposition, Rag recombinase recruitment, and ultimately *Tcra* rearrangement. These defects compromise thymocyte differentiation by limiting the number and diversity of sequential *Tcra* rearrangements. Hence, cohesin contributes to cellular differentiation in a well-characterised mammalian system.

Methods summary {#S1}
===============

The conditional *Rad21* allele was generated by inserting *LoxP* sites into introns 4 and 6 ([Supplementary fig. 1a](#SD2){ref-type="supplementary-material"}). Methods used for RT- and genomic PCR (ref. [@R2]), flow cytometry^[@R2]^, 3C analysis^[@R2]^, ChIP for cohesin^[@R2]^, histone modifications^[@R30]^ and Rag proteins^[@R30]^ have been described. See [supplementary methods](#SD3){ref-type="supplementary-material"} for other mouse strains, BrdU labeling and detection, ChIP-seq and RNA-seq protocols, ligation-mediated PCR, confocal microscopy, Tcra rearrangement assays and copy number measurements.
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![Genetic cohesin depleted in non-dividing thymocytes\
a) Thymocyte differentiation from left to right: CD4^−^ CD8^−^ double negative (DN) stages 1 to 4; CD4^+^ CD8^+^ double positive (DP), CD4^+^8^lo^; CD4 or CD8 single positive (SP) cells. Proliferation is in green, cell cycle arrest in red. Histograms show DNA content.\
b) Conditional *Rad21* allele (see [supplementary fig. 1a](#SD2){ref-type="supplementary-material"}).\
c) Real time genomic PCR of *Rad21* locus deletion, RT-PCR of *Rad21* RNA and western blotting of Rad21 protein.\
d) Cell numbers and flow cytometric analysis of thymocyte subsets in 6 week-old CD4Cre *Rad21*^lox/lox^ and CD4Cre *Rad21*^lox/lwt^ mice (mean ± SD, n = 12).\
e) Pulse chase analysis of CD4Cre *Rad21*^lox/wt^ and CD4Cre *Rad21*^lox/lox^ thymocytes. Dot blots are gated on BrdU^+^ cells (see [supplementary fig. 2b](#SD2){ref-type="supplementary-material"}).\
f) Continuous BrdU labelling for DP thymocyte turnover. See [supplementary Fig. 2c](#SD2){ref-type="supplementary-material"} for CD4^+^8^lo^ and CD4 SP subsets (mean ± SD, n = 3--5 per data point).\
g) Top: metaphase spreads of 2 day activated thymocytes stained for alpha-tubulin (green) and DNA (DAPI, blue, see [supplementary fig. 3](#SD2){ref-type="supplementary-material"}). Bottom: Cells recovered after 5 days.](nihms313087f1){#F1}

![Cohesin affects *Tcra* transcription Rag recombinase recruitment\
a) Rad21 ChIP-seq of the 3\' part of the *Tcra* locus in DP thymocytes. Arrowheads highlight cohesin sites at the Eα enhancer (black), the *Tcra* locus control region (grey), Jα promoters (turquoise), the TEA promoter (green) and between *Tcrd* elements and V gene segments (blue).\
b) RNA-seq of *Tcra* in CD4Cre *Rad21*^lox/lox^ (red) and control *Rad21*^lox/wt^ (black) DP thymocytes. Rad21 ChIP-seq is in blue.\
c) ChIP of H3K4me3 relative to total H3 in CD4Cre *Rad21*^lox/lox^ and control DP thymocytes. *Hbb* is a negative and *Actg* and *Elp4* are positive control loci (mean ± SE of 2 independent experiments). p=0.016 for all Jα elements; p=0.38 (NS) for proximal (Jα61--48) and p=0.004 for distal (Jα37--16) Jα elements.\
d) ChIP of Rag2 relative to total H3 as in c) (mean ± SE of 3 independent experiments). p=0.0001 for all Jα elements; p=0.054 (NS) for proximal (Jα61--48) and p=0.0001 for distal (Jα37--16) Jα elements.\
e) ChIP of Rag1 relative to total H3 as in c) (mean ± SE of 2 independent experiments). p=0.005 for all Jα elements; p=0.17 (NS) for proximal (Jα61--48) and p=0.003 for distal (Jα37--16) Jα elements.](nihms313087f2){#F2}

![Cohesin affects *Tcra* rearrangement\
a) Three-fold dilutions of genomic Vα8-Jα PCR products from CD71^+^ or CD71^−^ DP thymocytes visualised with ethidium bromide. *Cd14* is a genomic control.\
b) Genomic PCR products from small DP thymocytes visualised by Southern blotting with Jα-specific probes (left). Usage of the distal Jα22 element was reduced by 86% (middle, mean ± SE, n=3). Southern blotting of Vα8-Jα RT-PCR products from CD4Cre *Rad21*^lox/lox^ normalised to control DP thymocytes (right, mean ± SE, n=3).\
c) Double strand breaks in three-fold serially diluted genomic DNA from CD4Cre *Rad21^lox/lox^* and control DP thymocytes detected by ligation-mediated PCR.](nihms313087f3){#F3}

![Cohesin mediates long-range interactions between regulatory elements that control *Tcra* transcription\
a) Transcript copy number of the unrearranged *Tcra* J region in *Rag1*-deficient CD4Cre *Rad21*^lox/lox^ and *Rad21*^lox/wt^ DP thymocytes (mean ± SE, n=3).\
b) 3C analysis of long-range interactions between Eα and *Tcra* restriction fragments (shaded) in *Rag1*-deficient CD4Cre *Rad21*^lox/wt^ (black, mean ± SD, n=3), CD4Cre *Rad21*^lox/lox^ (red, mean ± SD, n=3) DP thymocytes and pre-B cells (grey, mean ± SD, n=3). Intervening HindIII fragment numbers and genomic distances are indicated. Stars: p \< 0.05 (grey: control thymocytes versus pre-B cells; red: control versus cohesin-depleted thymocytes; NS = not significant).\
c) TCR transgenes rescue the differentiation of cohesin-depleted thymocytes. Top: Percentages BrdU^+^ cells in CD4^+^8^lo^, CD4 SP and CD8 SP thymocytes. The differentiation of cohesin-deficient thymocytes is rescued by MHC class II-restricted (middle) and MHC class I-restricted TCR transgenes (bottom), n=3--5 per data point ± SD.](nihms313087f4){#F4}
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